Adjuvant anthracycline therapy as a prognostic factor in metastatic breast cancer

Author： Alba E.   Ribelles N.   Sevilla I.   Rueda A.   Alonso L.   Marquez A.   Ruiz I.   Miramón J.  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.66, Iss.1, 2001-03, pp. : 33-39

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Breast Cancer Angiogenesis: Therapy Target and Prognostic Factor

By Harris A.L.   Fox S.   Leek R.   Zhang H.   Scott P.   Bicknell R.   Gatter K.  

European Journal of Cancer, Vol. 31, Iss. 5, 1995-01 ,pp. : 831-832

Elsevier

Access to resources Recommend Favorite

Adjuvant Therapy of Breast Cancer

By Kaklamani Virginia   Gradishar William  

Cancer Investigation, Vol. 23, Iss. 6, 2005-09 ,pp. : 548-560

Informa Healthcare

Access to resources Recommend Favorite

Optimizing Anthracycline Therapy for Node Positive Breast Cancer

By Cardoso F.   Atalay G.   Piccart M.J.  

American Journal of Cancer, Vol. 1, Iss. 4, 2002-01 ,pp. : 257-268

Adis International

Access to resources Recommend Favorite

Adjuvant Chemotherapy in Early Breast Cancer: Optimal and Suboptimal Anthracycline-Containing Regimens

By Cocconi G.  

Breast Cancer Research and Treatment, Vol. 80, Iss. 3, 2003-08 ,pp. : 313-320

Springer Publishing Company

Access to resources Recommend Favorite

Adjuvant Therapy of Breast Cancer: An Overview

By Levitt Seymour H.   Kennedy B. J.  

Acta Oncologica, Vol. 37, Iss. 5, 1998-10 ,pp. : 403-409

Informa Healthcare

Access to resources Recommend Favorite